Miss Megan Yee
Boston (United States of America)
Characterization of major and clinically relevant non-major bleeding in the APEX trial
Event: ESC Congress 2018
Topic: Anticoagulants
Session: Oral anticoagulants : news from large trials and registries
Betrixaban compared to enoxaparin among obese acute medically ill subjects: an APEX trial subgroup analysis
Event: ESC Congress 2018
Topic: Obesity
Session: Obesity and cardiovascular disease
History of venous thromboembolism is associated with higher risk for recurrent venous thromboembolism: insights from the APEX trial
Event: ESC Congress 2017
Topic: Thrombosis and coagulation
Session: Latest on STEMI
Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy
Event: ESC Congress 2017
Topic: Atrial fibrillation (AF)
Session: Bleeding and LAA occlusion
Direct ugmentation of cholesterol efflux capacity in AMI atients: a PKPD substudy of AEGIS-I
Event: ESC Congress 2017
Topic: Pharmacology
Session: Inflammation, diabetes and their influence on the heart
ESC 365 is supported by
